These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3553756)

  • 1. Marijuana testing--how good is it?
    Moyer TP; Palmen MA; Johnson P; Charlson JR; Ellefson PJ
    Mayo Clin Proc; 1987 May; 62(5):413-7. PubMed ID: 3553756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
    Fraser AD; Worth D
    Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of six cannabinoid metabolite assays.
    Frederick DL; Green J; Fowler MW
    J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the EZ-SCREEN enzyme immunoassay test for detection of cocaine and marijuana metabolites in urine specimens.
    Schwartz RH; Bogema S; Thorne MM
    Pediatr Emerg Care; 1990 Jun; 6(2):147-9. PubMed ID: 2196539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity testing of the accuPINCH THC test.
    Jenkins AJ; Darwin WD; Huestis MA; Cone EJ; Mitchell JM
    J Anal Toxicol; 1995; 19(1):5-12. PubMed ID: 7723303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
    Niedbala RS; Kardos KW; Fritch DF; Kardos S; Fries T; Waga J; Robb J; Cone EJ
    J Anal Toxicol; 2001; 25(5):289-303. PubMed ID: 11499881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMIT cannabinoid assay: confirmation by RIA and GC/MS.
    O'Connor JE; Rejent TA
    J Anal Toxicol; 1981; 5(4):168-73. PubMed ID: 7024638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):443-9. PubMed ID: 8926739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of EMIT and RIA high volume test procedures for THC metabolites in urine utilizing GC/MS confirmation.
    Abercrombie ML; Jewell JS
    J Anal Toxicol; 1986; 10(5):178-80. PubMed ID: 3022068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.
    Moore C; Ross W; Coulter C; Adams L; Rana S; Vincent M; Soares J
    J Anal Toxicol; 2006 Sep; 30(7):413-8. PubMed ID: 16959132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False negative GC/MS assay for carboxy THC due to ibuprofen interference.
    Brunk SD
    J Anal Toxicol; 1988; 12(5):290-1. PubMed ID: 2852278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL; Middleton R; Sparks C
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite.
    Cone EJ; Yousefnejad D; Dickerson SL
    J Forensic Sci; 1990 Jul; 35(4):786-91. PubMed ID: 2202774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunoassays for cannabinoids in urine.
    Irving J; Leeb B; Foltz RL; Cook CE; Bursey JT; Willette RE
    J Anal Toxicol; 1984; 8(4):192-6. PubMed ID: 6471820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.